These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18940129)

  • 21. Familial chylomicronemia syndrome- an uncommon cause of acute pancreatitis with encephalopathy.
    Kota SK; Kota SK; Jammula S; Modi KD
    Indian J Gastroenterol; 2012 Sep; 31(5):277-9. PubMed ID: 23081844
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
    Nierman MC; Rip J; Twisk J; Meulenberg JJ; Kastelein JJ; Stroes ES; Kuivenhoven JA
    Neth J Med; 2005 Jan; 63(1):14-9. PubMed ID: 15719847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Diagnosis and Management of Primary Chylomicronemia.
    Okazaki H; Gotoda T; Ogura M; Ishibashi S; Inagaki K; Daida H; Hayashi T; Hori M; Masuda D; Matsuki K; Yokoyama S; Harada-Shiba M
    J Atheroscler Thromb; 2021 Sep; 28(9):883-904. PubMed ID: 33980761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lipoprotein lipase deficiency. Apropos of 2 cases].
    Guyot A; Bost M; Groslambert P; Foulon T; Jeannoel P
    Pediatrie; 1986; 41(1):33-9. PubMed ID: 3725507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management.
    Brown WV; Goldberg I; Duell B; Gaudet D
    J Clin Lipidol; 2018; 12(2):254-263. PubMed ID: 29534878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting APOC3 in the familial chylomicronemia syndrome.
    Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL
    N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy.
    Wilson CJ; Priore Oliva C; Maggi F; Catapano AL; Calandra S
    Ann Neurol; 2003 Jun; 53(6):807-10. PubMed ID: 12783430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment.
    Stefanutti C; Gozzer M; Pisciotta L; D'Eufemia P; Bosco G; Morozzi C; Papadia F; Shafii M; Di Giacomo S; Bertolini S
    Atheroscler Suppl; 2013 Jan; 14(1):73-6. PubMed ID: 23357145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
    Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.
    Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y
    Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
    Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
    Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report.
    Lin MH; Tian XH; Hao XL; Fei H; Yin JL; Yan DD; Li T
    BMC Pregnancy Childbirth; 2020 May; 20(1):272. PubMed ID: 32375710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.
    Paquette M; Hegele RA; Paré G; Baass A
    J Clin Lipidol; 2018; 12(2):506-510. PubMed ID: 29452893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations.
    Vigna GB; Citroni N; Tarugi P; Fellin R
    J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chylomicronemia syndrome--pathophysiology, clinical aspects and therapy].
    Klör HU
    Klin Wochenschr; 1990; 68 Suppl 22():68-75. PubMed ID: 2087083
    [No Abstract]   [Full Text] [Related]  

  • 37. Familial chylomicronemia syndrome: a case report.
    Susheela AT; Vadakapet P; Pillai L; Thampi S
    J Med Case Rep; 2021 Jan; 15(1):5. PubMed ID: 33419463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary hyperchylomicronemia and gene defects].
    Iwasaki M; Tada N
    Nihon Rinsho; 1999 Dec; 57(12):2759-64. PubMed ID: 10638209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
    Williams L; Rhodes KS; Karmally W; Welstead LA; Alexander L; Sutton L;
    J Clin Lipidol; 2018; 12(4):908-919. PubMed ID: 29804909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.
    Lennertz A; Parhofer KG; Samtleben W; Bosch T
    Ther Apher; 1999 Aug; 3(3):227-33. PubMed ID: 10427620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.